Dr. Melodie R. Winawer, MD

Dr. Winawer practices at Trustees of Columbia University in the City of New York in Fort Lee, New Jersey.

Dr. Winawer's NPI, 1538230222, was assigned on November 13, 2006. Dr. Winawer graduated from Perelman School of Medicine - Philadelphia in 1994. Dr. Winawer holds New York license 201517.

Dr. Winawer's primary practice is Trustees of Columbia University in the City of New York, at 400 Kelby St, Fort Lee, NJ 07024 in Bergen County. The practice phone is (646) 317-7111.

Dr. Winawer's primary practice is Trustees of Columbia University in the City of New York in Fort Lee, New Jersey. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Winawer to 1 more group practice or clinic, 1 skilled nursing facility and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Winawer practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Winawer's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Winawer is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Winawer's licenses on file in 2 states: New York and Florida.

Dmand AI lists acute mini-stroke (TIA), carpal tunnel syndrome, cerebrovascular disease, epilepsy, fibromyalgia and chronic pain, lower back pain, migraine and chronic headache and muscle weakness among the conditions Dr. Winawer treats.

CMS data shows 47 Medicare services from Dr. Winawer across 3 procedure codes in 2024, all of them office visits, for 45 Medicare patients. Medicare paid $6,520 for them. Every service was in an office.

CMS counts 45 Medicare patients who saw Dr. Winawer in 2024. The largest group is 75 to 84, with 21 patients. 64% of them have high cholesterol, and 53% have high blood pressure. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Winawer's median patient age at 52, with 71% women.

In 2024, Dr. Winawer wrote 209 Medicare Part D claims for 54 patients. 92% of them were for generic drugs. CMS names the drug for 92 of them, across 4 drugs with 11 or more claims each, at $1,059 in total drug cost. In 2023, CMS named 129 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Winawer for performance year 2024, reported through an alternative payment model (APM). Dr. Winawer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Winawer as offering telehealth.

Dmand AI links 47 papers to Dr. Winawer, published from 2007 to 2023. 2022 was the busiest year, with 4. The most frequent topics are Epilepsy, Genetic Predisposition to Disease and Phenotype. Dr. Winawer has published most often in Epilepsia. Dr. Winawer's most frequent co-authors are Andres M. Kanner, MD, Jerry Jeh Shih, MD and Wendy Chung, MD.

CMS Open Payments shows 11 general payments to Dr. Winawer from 5 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $77.

Dr. Winawer graduated from Perelman School of Medicine - Philadelphia in 1994.

Dr. Winawer is in network with 13 carriers, including Aetna, Elevance and United Healthcare. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.